ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Michael Stewart, MD, speaks about aflibercept 8 mg, the newly approved version of Eylea.
He presents the results of the PULSAR and PHOTON studies, which showed promising results for age-related macular degeneration and diabetic macular edema with long injection intervals.